Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at the
By Giulia Corso|2024-06-27T08:32:44+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at the
By Giulia Corso|2024-05-29T13:40:27+00:00May 23rd, 2024|Extracellular vesicles, mesenchymal stromal cells, recent highlights EV, telomerized cells|
Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, AustriaOur telomerized human adipose derived MSC (ASC/TERT1, also known in
By Giulia Corso|2024-06-10T11:38:56+00:00April 29th, 2024|EVscale, Extracellular vesicles, recent highlights EV|
Evercyte is happy to introduce the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the
By Giulia Corso|2024-06-10T11:37:51+00:00February 16th, 2024|PODO/TERT256, telomerized cells|
Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an
By Giulia Corso|2023-12-07T08:27:20+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
By Giulia Corso|2023-11-22T14:26:44+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our services
By Giulia Corso|2023-10-27T13:05:07+00:00October 27th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, AustriaWe participated to the first MOVE symposium held
By Giulia Corso|2023-12-01T09:15:19+00:00September 19th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
By Giulia Corso|2023-09-19T07:33:39+00:00August 4th, 2023|3Rs, collaboration, organ-on-a-chip, RPTEC/TERT1|
Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with
By Giulia Corso|2023-07-11T09:18:04+00:00May 4th, 2023|EU funded project, Extracellular vesicles and ageing, mesenchymal stromal cells|
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on